Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 13, 2018 at 1:34 PM EDT

Why Wedbush Sees Albireo More Than Doubling

Albiero Pharma, Inc. (NASDAQ: ALBO) recently received some positive news from the U.S. Food and Drug Administration (FDA) and it…

Chris Lange | Jun 13, 2018 at 11:11 AM EDT

Why scPharma Shares Are Bombing

scPharmaceuticals Inc. (NASDAQ: SCPH) saw its shares drop massively on Wednesday after the firm announced that it had received a…

Lee Jackson | Jun 13, 2018 at 9:42 AM EDT

4 Pharmaceutical Services Stocks To Buy With Big Upside Potential

Analysts at Jefferies recently reviewed several pharmaceutical services company stocks and put a Buy rating on four outstanding performers.

Chris Lange | Jun 12, 2018 at 1:31 PM EDT

Why Sage Therapeutics Is Booming

Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan…

Chris Lange | Jun 12, 2018 at 10:54 AM EDT

Short Sellers Up the Ante For Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data…

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

Chris Lange | Jun 11, 2018 at 12:42 PM EDT

Is CRISPR in Touble After New STAT Report?

Shares of CRISPR Therapeutics tumbled after a report was released that gene-edited cells might cause cancer. The implications of this…

Chris Lange | Jun 11, 2018 at 8:57 AM EDT

Are Envision Shareholders Getting Enough in the Acquisition?

Envision Healthcare Corp. (NYSE: EVHC) saw its shares make a slight bump early on Monday morning after it was announced…

Chris Lange | Jun 9, 2018 at 9:25 AM EDT

Biopharma Companies to Watch This Week and for the Rest of June

Here 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week…

Chris Lange | Jun 8, 2018 at 10:56 AM EDT

EDAP Wins Big With FDA Clearance

EDAP TMS shares saw an incredible gain to close out the week after the company announced that it received clearance…

Chris Lange | Jun 7, 2018 at 10:15 AM EDT

Proteostasis Therapeutics Stumbles Despite Positive Early Stage Data

Proteostasis Therapeutics saw its shares slide early on Thursday after the company reported positive data from its early stage trial…

Chris Lange | Jun 6, 2018 at 1:35 PM EDT

Pfizer Drops $600 Million in Its Venture Capital Arm

Pfizer shares were up marginally on Wednesday after the pharma giant announced that it would be committing over half a…

Chris Lange | Jun 6, 2018 at 11:30 AM EDT

What the Management Picture for CVS and Aetna Will Look Like Going Forward

CVS Health and Aetna are closing in on finalizing the acquisition, and the companies have now announced the management team…

Chris Lange | Jun 6, 2018 at 10:05 AM EDT

Why Axovant Shares More Than Doubled

Axovant Sciences shares more than doubled on Wednesday after the company announced a new licensing agreement.

Chris Lange | Jun 5, 2018 at 1:35 PM EDT

Verrica Pharmaceuticals Closes in on IPO

Verrica Pharmaceuticals expects to price 5 million shares in the range that results in an initial public offering valued up…

1 … 130 131 132 133 134 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Wedbush Sees Albireo More Than Doubling

Why scPharma Shares Are Bombing

4 Pharmaceutical Services Stocks To Buy With Big Upside Potential

Why Sage Therapeutics Is Booming

Short Sellers Up the Ante For Major Biotechs

Major Pharmaceuticals Scare Off Short Sellers

Is CRISPR in Touble After New STAT Report?

Are Envision Shareholders Getting Enough in the Acquisition?

Biopharma Companies to Watch This Week and for the Rest of June

EDAP Wins Big With FDA Clearance

Proteostasis Therapeutics Stumbles Despite Positive Early Stage Data

Pfizer Drops $600 Million in Its Venture Capital Arm

What the Management Picture for CVS and Aetna Will Look Like Going Forward

Why Axovant Shares More Than Doubled

Verrica Pharmaceuticals Closes in on IPO

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Why Wedbush Sees Albireo More Than Doubling

Why scPharma Shares Are Bombing

4 Pharmaceutical Services Stocks To Buy With Big Upside Potential

Why Sage Therapeutics Is Booming

Short Sellers Up the Ante For Major Biotechs

Major Pharmaceuticals Scare Off Short Sellers

Is CRISPR in Touble After New STAT Report?

Are Envision Shareholders Getting Enough in the Acquisition?

Biopharma Companies to Watch This Week and for the Rest of June

EDAP Wins Big With FDA Clearance

Proteostasis Therapeutics Stumbles Despite Positive Early Stage Data

Pfizer Drops $600 Million in Its Venture Capital Arm

What the Management Picture for CVS and Aetna Will Look Like Going Forward

Why Axovant Shares More Than Doubled

Verrica Pharmaceuticals Closes in on IPO

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how